Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies Article

sustainable development goals

publication date

  • March 1, 2018

webpage

published in

keywords

  • Clear or almost clear skin
  • Clinical trial
  • North America
  • Patient-reported outcomes
  • Pooled
  • Psoriasis
  • Quality of life
  • Secukinumab

start page

  • 17

end page

  • 32

volume

  • 8

issue

  • 1